OpenEvidence × John Wiley & Sons, Inc.
Wiley announced a strategic partnership with the medical AI platform OpenEvidence to license its peer-reviewed content for use in the clinical AI tool. [33, 37] The agreement allows clinicians using OpenEvidence to access evidence-based insights from hundreds of Wiley journals and reference works, including the Cochrane Database of Systematic Reviews. [32, 34] While no specific financial terms were disclosed, the deal was highlighted as a 'landmark partnership' in Wiley's subsequent annual earnings report. [35]
The asset
A strategic partnership to integrate a large portfolio of Wiley's peer-reviewed scientific and medical content into the OpenEvidence medical AI platform.
The record
- Seller status
- Going concern
- Sector
- academic publishing
- Modalities
- text
- Jurisdiction
- US
What it means if you hold data
This deal exemplifies a key strategy for academic publishers: embedding their high-value, vetted content directly into the AI-powered workflows of professionals. Rather than just selling raw data for training, this partnership integrates content as a trusted evidence layer at the point of care, creating a more defensible and potentially recurring revenue model. [31, 34]